Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1988 Sep 1;168(3):971–982. doi: 10.1084/jem.168.3.971

Immunogenicity of liposome-bound hyaluronate in mice. At least two different antigenic sites on hyaluronate are identified by mouse monoclonal antibodies

PMCID: PMC2189035  PMID: 2459294

Abstract

Hyaluronate (HA) was previously demonstrated to be immunogenic in rabbits. The immunogenicity of HA in mice was studied. Hyaluronidase- digested streptococcal HA (IA1) covalently linked to liposomes (IA1- liposomes) were produced for immunization. Mice immunized with IA1- liposomes developed measurable serum antibodies to IA1, while mice immunized with IA1 in Freund's adjuvant did not. mAbs produced by two stable hybridomas (10G6 and 5F11) from mice immunized with IA1- liposomes produced IgG antibody reactive with HA in ELISA. 10G6 had a much higher avidity for liposome-bound IA1 than free IA1, while 5F11 did not, suggesting that the mode of presentation of IA1 is important in HA immunogenicity and antigenicity. Both mAbs recognized terminal HA immunodeterminants exposed by hyaluronidase treatment. Sonication had no effect on HA reactivity for either mAb. However, ascorbic acid treatment significantly reduced the antigenicity of HA for mAb 5F11, but not 10G6. Only 10G6 was inhibited by glucuronic acid. Electrostatic forces appear to play a role in the binding site of 5F11, but not 10G6. 5F11 crossreacts with heparan sulfate and phosphorylcholine, while 10G6 did not crossreact with any glycosaminoglycans or phosphorylated compounds tested. These results confirm that HA is immunogenic. They suggest that the mode of presentation of HA is important for the induction of the immune response, and in HA antigenicity. At least two different antigenic sites on HA were demonstrated. 10G6 recognizes a terminal HA antigenic site expressed on IA1-liposomes that contains glucuronic acid in its immunodominant site. 5F11 recognizes an HA antigenic site in which electrostatic forces appear to play a role, is sensitive to ascorbic acid treatment, and is crossreactive with heparan sulfate. The use of mAbs should facilitate immunologic studies of HA.

Full Text

The Full Text of this article is available as a PDF (692.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BITTER T., MUIR H. M. A modified uronic acid carbazole reaction. Anal Biochem. 1962 Oct;4:330–334. doi: 10.1016/0003-2697(62)90095-7. [DOI] [PubMed] [Google Scholar]
  2. Diamond B., Scharff M. D. Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5841–5844. doi: 10.1073/pnas.81.18.5841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Faaber P., Rijke T. P., van de Putte L. B., Capel P. J., Berden J. H. Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest. 1986 Jun;77(6):1824–1830. doi: 10.1172/JCI112508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fillit H. M., McCarty M., Blake M. Induction of antibodies to hyaluronic acid by immunization of rabbits with encapsulated streptococci. J Exp Med. 1986 Sep 1;164(3):762–776. doi: 10.1084/jem.164.3.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fillit H., Damle S. P., Gregory J. D., Volin C., Poon-King T., Zabriskie J. Sera from patients with poststreptococcal glomerulonephritis contain antibodies to glomerular heparan sulfate proteoglycan. J Exp Med. 1985 Feb 1;161(2):277–289. doi: 10.1084/jem.161.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fischetti V. A. Requirements for the opsonic activity of human IgG directed to type 6 group A streptococci: net basic charge and intact Fc region. J Immunol. 1983 Feb;130(2):896–902. [PubMed] [Google Scholar]
  7. Greenwald R. A., Moak S. A. Degradation of hyaluronic acid by polymorphonuclear leukocytes. Inflammation. 1986 Mar;10(1):15–30. doi: 10.1007/BF00916037. [DOI] [PubMed] [Google Scholar]
  8. Hale C. W. Studies on diffusing factors: 4. The action of reducing agents on hyaluronic acid and other polysaccharides. Biochem J. 1944;38(5):362–368. doi: 10.1042/bj0380362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Herbst H., Lavanchy D., Braun D. G. Grouping of haemolytic streptococci by monoclonal antibodies: determinant specificity, cross-reactivity and affinity. Ann Immunol (Paris) 1983 Nov-Dec;134D(3):349–371. doi: 10.1016/s0769-2625(83)80027-0. [DOI] [PubMed] [Google Scholar]
  10. Hirst G. K. THE EFFECT OF A POLYSACCHARIDE-SPLITTING ENZYME ON STREPTOCOCCAL INFECTION. J Exp Med. 1941 Mar 31;73(4):493–506. doi: 10.1084/jem.73.4.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Humphrey J. H. Antigenic properties of hyaluronic acid. Biochem J. 1943 Oct;37(4):460–463. doi: 10.1042/bj0370460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kanwar Y. S. Biophysiology of glomerular filtration and proteinuria. Lab Invest. 1984 Jul;51(1):7–21. [PubMed] [Google Scholar]
  13. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  14. Laurent T. C., Dahl I. M., Dahl L. B., Engström-Laurent A., Eriksson S., Fraser J. R., Granath K. A., Laurent C., Laurent U. B., Lilja K. The catabolic fate of hyaluronic acid. Connect Tissue Res. 1986;15(1-2):33–41. doi: 10.3109/03008208609001971. [DOI] [PubMed] [Google Scholar]
  15. McNeil J. D., Wiebkin O. W., Betts W. H., Cleland L. G. Depolymerisation products of hyaluronic acid after exposure to oxygen-derived free radicals. Ann Rheum Dis. 1985 Nov;44(11):780–789. doi: 10.1136/ard.44.11.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Miettinen A., Stow J. L., Mentone S., Farquhar M. G. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening. J Exp Med. 1986 May 1;163(5):1064–1084. doi: 10.1084/jem.163.5.1064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schwartz R. S., Stollar B. D. Origins of anti-DNA autoantibodies. J Clin Invest. 1985 Feb;75(2):321–327. doi: 10.1172/JCI111704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Scott J. E., Tigwell M. J. Periodate oxidation and the shapes of glycosaminoglycuronans in solution. Biochem J. 1978 Jul 1;173(1):103–114. doi: 10.1042/bj1730103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Seastone C. V. THE VIRULENCE OF GROUP C HEMOLYTIC STREPTOCOCCI OF ANIMAL ORIGIN. J Exp Med. 1939 Sep 30;70(4):361–378. doi: 10.1084/jem.70.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Szu S. C., Zon G., Schneerson R., Robbins J. B. Ultrasonic irradiation of bacterial polysaccharides. Characterization of the depolymerized products and some applications of the process. Carbohydr Res. 1986 Sep 1;152:7–20. doi: 10.1016/s0008-6215(00)90283-0. [DOI] [PubMed] [Google Scholar]
  21. Underhill C. B. Naturally-occurring antibodies which bind hyaluronate. Biochem Biophys Res Commun. 1982 Oct 29;108(4):1488–1494. doi: 10.1016/s0006-291x(82)80075-2. [DOI] [PubMed] [Google Scholar]
  22. Zabriskie J. B. Mimetic relationships between group A streptococci and mammalian tissues. Adv Immunol. 1967;7:147–188. doi: 10.1016/s0065-2776(08)60128-5. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES